ATE199724T1 - Verfahren zur herstellung von 1-(2'-desoxy-2',2'- difluoro-d-ribo-pentofuranosyl)-cytosin aus 2- desoxy-2,2-difluoro-beta-d-ribo-pentopyranose - Google Patents

Verfahren zur herstellung von 1-(2'-desoxy-2',2'- difluoro-d-ribo-pentofuranosyl)-cytosin aus 2- desoxy-2,2-difluoro-beta-d-ribo-pentopyranose

Info

Publication number
ATE199724T1
ATE199724T1 AT96300419T AT96300419T ATE199724T1 AT E199724 T1 ATE199724 T1 AT E199724T1 AT 96300419 T AT96300419 T AT 96300419T AT 96300419 T AT96300419 T AT 96300419T AT E199724 T1 ATE199724 T1 AT E199724T1
Authority
AT
Austria
Prior art keywords
ribo
difluoro
deoxy
pentofuranosyl
cytosine
Prior art date
Application number
AT96300419T
Other languages
English (en)
Inventor
David D Wirth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE199724T1 publication Critical patent/ATE199724T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96300419T 1995-02-03 1996-01-22 Verfahren zur herstellung von 1-(2'-desoxy-2',2'- difluoro-d-ribo-pentofuranosyl)-cytosin aus 2- desoxy-2,2-difluoro-beta-d-ribo-pentopyranose ATE199724T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/383,165 US5559222A (en) 1995-02-03 1995-02-03 Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose

Publications (1)

Publication Number Publication Date
ATE199724T1 true ATE199724T1 (de) 2001-03-15

Family

ID=23511995

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96300419T ATE199724T1 (de) 1995-02-03 1996-01-22 Verfahren zur herstellung von 1-(2'-desoxy-2',2'- difluoro-d-ribo-pentofuranosyl)-cytosin aus 2- desoxy-2,2-difluoro-beta-d-ribo-pentopyranose

Country Status (10)

Country Link
US (2) US5559222A (de)
EP (1) EP0727433B1 (de)
JP (1) JPH08245685A (de)
AT (1) ATE199724T1 (de)
CA (1) CA2168080C (de)
DE (1) DE69612024T2 (de)
DK (1) DK0727433T3 (de)
ES (1) ES2154788T3 (de)
GR (1) GR3035931T3 (de)
PT (1) PT727433E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19741715A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
CN1438981A (zh) * 2000-04-21 2003-08-27 罗迪亚/奇莱克斯公司 制备r-1-(芳氧基)丙-2-醇的方法
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
JP2008531680A (ja) * 2005-03-04 2008-08-14 ダブール・ファーマ・リミテッド βアノマーが富化された21−デオキシ−21,21−ジフルオロ−D−リボフラノシルヌクレオシドの調製のための中間体と方法
CA2610283C (en) * 2005-06-03 2011-08-30 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2-deoxy-2,2-diflouro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
AU2011202539B2 (en) * 2005-06-03 2012-07-05 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
JP2009526782A (ja) * 2006-02-07 2009-07-23 ケマジス・リミテッド ゲムシタビンおよび関連中間体の製造方法
US20070249823A1 (en) * 2006-04-20 2007-10-25 Chemagis Ltd. Process for preparing gemcitabine and associated intermediates
CN101024667B (zh) * 2007-03-30 2011-01-26 湖北益泰药业有限公司 盐酸吉西他宾的合成方法
US20080262215A1 (en) * 2007-04-23 2008-10-23 Chemagis Ltd. Gemcitabine production process

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
ATE92499T1 (de) * 1984-12-04 1993-08-15 Lilly Co Eli Tumorbehandlung bei saeugetieren.
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
CA1324128C (en) * 1987-08-28 1993-11-09 Ta-Sen Chou 2', 2'-difluoronucleosides
US5223608A (en) * 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US4954623A (en) * 1989-03-20 1990-09-04 Eli Lilly And Company Recovery of difluoro sugar
US5401838A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5426183A (en) * 1992-06-22 1995-06-20 Eli Lilly And Company Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів

Also Published As

Publication number Publication date
DE69612024T2 (de) 2001-09-06
CA2168080C (en) 2007-05-29
US5608043A (en) 1997-03-04
PT727433E (pt) 2001-06-29
EP0727433A1 (de) 1996-08-21
EP0727433B1 (de) 2001-03-14
JPH08245685A (ja) 1996-09-24
GR3035931T3 (en) 2001-08-31
DK0727433T3 (da) 2001-04-17
DE69612024D1 (de) 2001-04-19
ES2154788T3 (es) 2001-04-16
US5559222A (en) 1996-09-24
CA2168080A1 (en) 1996-08-04

Similar Documents

Publication Publication Date Title
ATE229960T1 (de) Verfahren zur herstellung von 13-ether-derivaten von milbemycinen und zwischenprodukte
ATE207859T1 (de) Verfahren zur herstellung von pentafluorethan
ATE199724T1 (de) Verfahren zur herstellung von 1-(2'-desoxy-2',2'- difluoro-d-ribo-pentofuranosyl)-cytosin aus 2- desoxy-2,2-difluoro-beta-d-ribo-pentopyranose
DE69132276D1 (de) Verfahren zur herstellung von nukleotiden
ATE162530T1 (de) 5-methyluridin-verfahren zur herstellung von 2',3'-didehydro-3'-desoxythymidin (d4t) im grossmassstab
ATE86978T1 (de) Verfahren zur herstellung von 3,5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer.
ATE178903T1 (de) Sulfamat-derivate von 1,3,5(10)-estratrien- derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE210136T1 (de) Verfahren zur herstellung von alkylhydrogenchlorsilanen
ATE85030T1 (de) Verfahren zur herstellung von wasserstoffperoxid.
ATE200544T1 (de) Fachwerk und gefacheelement und verfarhren zur herstellung eines gefacheelements
ATE174601T1 (de) Verfahren zur herstellung von bisnoraldehyden aus bisnoralkohol
ATE117994T1 (de) Verfahren zur herstellung von 2-chlor-5- chlormethylpyridin.
ATE148707T1 (de) Verfahren zur herstellung von 2',3'-didehydro- 2'3'-didesoxynukleosiden im grossmassstab
DE59608635D1 (de) Neues verfahren zur herstellung von nucleosiden
DE69912264D1 (de) Verfahren zur herstellung chiraler (s)-2,3-disubstituierter 1-propylamin-derivate
ATE156833T1 (de) Verfahren zur herstellung von azt und derivaten davon
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE147749T1 (de) Verfahren zur herstellung von azt(3'-azido-3'- desoxythymidin) und diebezüglichen verbindungen
DE3765651D1 (de) Verfahren zur herstellung einer synthesefaser und einer orientierten synthesefaser sowie nach diesem verfahren hergestellte orientierte synthesefaser.
DE59812518D1 (de) Substituierte tetrahydropyranderivate sowie verfahren zu deren herstellung
ATE138927T1 (de) Verfahren zur herstellung von desoxynukleosiden
DE68916022D1 (de) Verfahren zur herstellung von wasserstoffgas.
ATE7700T1 (de) 2-hydroxy-1,2,4-butantricarbonsaeure-oligoribosi - derivate, verfahren zu ihrer herstellung und ihre verwendung als prophylaktische mittel gegen zahnkaries.
ATE213734T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen
ATE241619T1 (de) Verfahren zur herstellung von nukleosid-analogen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification